Athos Capital’s Rockwell Medical RMTI Stock Holding History

Athos Capital’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-73	Closed	-$1.05M	–	33
2017 Q3	$1.05M	Buy	+73	New	+$55.8K	0.79%	22

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Athos Capital's RMTI Position: Q4 2017 in Review

Athos Capital sold out of Rockwell Medical (RMTI) in Q4 2017, closing a stake of 73 shares — an estimated $1.05M sold.

Athos Capital first reported a position in RMTI in Q3 2017 and held it in 1 quarter. The position peaked at $1.05M in Q3 2017. 83 funds tracked by Wall St. Rank hold RMTI as of Q4 2017.

Athos Capital reported no remaining Rockwell Medical position as of Q4 2017 after selling out during the quarter.
Athos Capital sold 73 Rockwell Medical shares in Q4 2017, an estimated $1.05M.
Athos Capital first reported a position in Rockwell Medical in Q3 2017 and held it in 1 quarter.
Athos Capital's Rockwell Medical position peaked at $1.05M in Q3 2017.
83 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2017.

Based on Athos Capital's 13F filing for Q4 2017, filed 9 Feb 2018.